370 related articles for article (PubMed ID: 25131730)
1. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
Lai CY; Liu YL; Yu GY; Maa MC; Leu TH; Xu C; Luo Y; Xiang R; Chuang TH
Vaccine; 2014 Sep; 32(43):5593-9. PubMed ID: 25131730
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
[TBL] [Abstract][Full Text] [Related]
3. Selective and direct activation of human neutrophils but not eosinophils by Toll-like receptor 8.
Janke M; Poth J; Wimmenauer V; Giese T; Coch C; Barchet W; Schlee M; Hartmann G
J Allergy Clin Immunol; 2009 May; 123(5):1026-33. PubMed ID: 19361845
[TBL] [Abstract][Full Text] [Related]
4. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
[TBL] [Abstract][Full Text] [Related]
5. A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition.
Liu J; Xu C; Hsu LC; Luo Y; Xiang R; Chuang TH
Mol Immunol; 2010 Feb; 47(5):1083-90. PubMed ID: 20004021
[TBL] [Abstract][Full Text] [Related]
6. Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.
Zhu J; Lai K; Brownile R; Babiuk LA; Mutwiri GK
Mol Immunol; 2008 Jun; 45(11):3238-43. PubMed ID: 18439678
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a functional, alternatively spliced Toll-like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens.
Philbin VJ; Iqbal M; Boyd Y; Goodchild MJ; Beal RK; Bumstead N; Young J; Smith AL
Immunology; 2005 Apr; 114(4):507-21. PubMed ID: 15804288
[TBL] [Abstract][Full Text] [Related]
8. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation.
Larangé A; Antonios D; Pallardy M; Kerdine-Römer S
J Leukoc Biol; 2009 Apr; 85(4):673-83. PubMed ID: 19164127
[TBL] [Abstract][Full Text] [Related]
9. Identification, characterization and genetic mapping of TLR7, TLR8a1 and TLR8a2 genes in rainbow trout (Oncorhynchus mykiss).
Palti Y; Gahr SA; Purcell MK; Hadidi S; Rexroad CE; Wiens GD
Dev Comp Immunol; 2010 Feb; 34(2):219-33. PubMed ID: 19825389
[TBL] [Abstract][Full Text] [Related]
10. Differences in TLR7/8 activation between monocytes and macrophages.
Eng HL; Hsu YY; Lin TM
Biochem Biophys Res Commun; 2018 Feb; 497(1):319-325. PubMed ID: 29448098
[TBL] [Abstract][Full Text] [Related]
11. Synthetic oligoribonucleotides containing arabinonucleotides act as agonists of TLR7 and 8.
Lan T; Bhagat L; Wang D; Dai M; Kandimalla ER; Agrawal S
Bioorg Med Chem Lett; 2009 Apr; 19(7):2044-7. PubMed ID: 19269175
[TBL] [Abstract][Full Text] [Related]
12. The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy.
Smits EL; Ponsaerts P; Berneman ZN; Van Tendeloo VF
Oncologist; 2008 Aug; 13(8):859-75. PubMed ID: 18701762
[TBL] [Abstract][Full Text] [Related]
13. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.
Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS
J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492
[TBL] [Abstract][Full Text] [Related]
14. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G
Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130
[TBL] [Abstract][Full Text] [Related]
15. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.
Hurst J; Prinz N; Lorenz M; Bauer S; Chapman J; Lackner KJ; von Landenberg P
Immunobiology; 2009; 214(8):683-91. PubMed ID: 19249118
[TBL] [Abstract][Full Text] [Related]
16. Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands.
Tanji H; Ohto U; Shibata T; Miyake K; Shimizu T
Science; 2013 Mar; 339(6126):1426-9. PubMed ID: 23520111
[TBL] [Abstract][Full Text] [Related]
17. RNA recognition via TLR7 and TLR8.
Hornung V; Barchet W; Schlee M; Hartmann G
Handb Exp Pharmacol; 2008; (183):71-86. PubMed ID: 18071655
[TBL] [Abstract][Full Text] [Related]
18. Dual or triple activation of TLR7, TLR8, and/or TLR9 by single-stranded oligoribonucleotides.
Forsbach A; Samulowitz U; Völp K; Hofmann HP; Noll B; Tluk S; Schmitz C; Wader T; Müller C; Podszuweit A; Lohner A; Curdt R; Uhlmann E; Vollmer J
Nucleic Acid Ther; 2011 Dec; 21(6):423-36. PubMed ID: 22196370
[TBL] [Abstract][Full Text] [Related]
19. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies.
Lan T; Dai M; Wang D; Zhu FG; Kandimalla ER; Agrawal S
J Med Chem; 2009 Nov; 52(21):6871-9. PubMed ID: 19824640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]